Skip to main content

Post-IPO Equity Health Care Companies

Explore 434 health care startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
434
Total Funding
$1.6B
Avg Funding
$62.5M
Cities
21

Export 434 Post-IPO Equity Health Care Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
South San Francisco, United States
$12.2M
raised

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$5.0M
raised

Avenue Therapeutics is a specialty pharmaceutical company that acquires/in-licenses, develops and commercializes products.

Oct 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$55K
raised

Nurosene Health is a technology-driven wellness company that helps healthy habits improve their brain, mind, and body.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Kelowna, Canada
$358K
raised

Rize Oncology develops a platform that allows to conjugate or tether donor DNA templates.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Hayward, United States
$250.0M
raised

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Carlsbad, United States
$3.0M
raised

Biora Therapeutics is the biotech company.

Oct 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Malmö, Sweden
$3.2M
raised

Pila Pharma is a TRPV1-platform focused company developing oral treatments for type-2 diabetes, obesity, and pain.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Houston, United States
$8.0M
raised

Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

West Point, United States
$3.3M
raised

Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.

Oct 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Saint Laurent, Canada
$101.2M
raised

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

Oct 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Milano, Italy
$15.0M
raised

Genenta Science is a biotechnology company that develops gene transfer therapy for the treatment of cancer tumors.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oslo, Norway
$32.3M
raised

Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer.

Oct 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Grand Cayman, Cayman Islands
$500K
raised

G Medical Innovations is a next-generation mobile health (mHealth) and e-health company.

Oct 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$155.3M
raised

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Miami, United States
$1.9M
raised

Earth Science Tech is a unique Science based Biotechnology company that brings Nature’s Pharmacy to the public.

Oct 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
South San Francisco, United States
$100.0M
raised

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

Oct 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$75K
raised

Vext Science is an agricultural technology company that utilizes and distributes cannabis products.

Oct 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlsbad, United States
$1.4M
raised

Aurora is an early-stage start-up company focused on bringing advanced solutions to the spinal implant market.

Oct 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Woodbridge, Canada
$1.1M
raised

UniDoc is a healthcare centre.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Eagle, United States
$108.5M
raised

The Pennant Group provide healthcare services through 75 home health and hospice agencies.

Oct 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Vancouver, Canada
$5.0M
raised

Keep your teeth healthy and white with Brüush - a premium electric toothbrush subscription with a luxury look and feel

Oct 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$250.0M
raised

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lehi, United States
$30.0M
raised

Owlet Baby Care offers a health monitor that allows parents to view their child's vital signs in real-time.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Watertown, United States
$225.0M
raised

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$250.0M
raised

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 401 to 425 of 434 companies

Ready to Connect with Post-IPO Equity Health Care Startups?

Get verified founder emails, funding details, and company data for 434 post-ipo equity health care companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked